Orica Shares Soar 40% on Record Profit: Is It Too Late to Buy or Time to Wait?
Ujjwal Maheshwari, November 14, 2025
Orica Limited (ASX: ORI) has surged 40% in 2025 to trade around $23, capping off the rally this week with its highest profit in 13 years at $992 million EBIT. Yet despite the record result, shares rose just 1.2% on the announcement, signalling the market had already anticipated the strong performance. For investors wondering whether to chase the momentum or wait for a pullback, the answer hinges on valuation discipline and patience.
What are the Best Mining Stocks to invest in right now?
Check our buy/sell tips
Orica’s $992M Record Profit Reveals Operational Leverage at Work
The fiscal 2025 result validates Orica’s positioning in the current mining boom, but the real story lies in how the company is generating profits. The $992 million EBIT represents the highest profit in 13 years, with strong growth delivered across all operating segments. This wasn’t merely a volume story; Orica achieved margin expansion by shifting its product mix towards premium offerings.
Here’s what’s driving the transformation:
– Digital product adoption: Higher-margin solutions like BlastIQ and automation technologies are gaining traction with miners seeking efficiency improvements
– Pricing discipline: Industry consolidation has allowed better pricing across commercial explosives markets
– Commodity exposure: Strong gold and copper prices are boosting explosives demand, with Orica commanding approximately 28% of the global commercial explosives market across 100+ countries
The concept of operational leverage matters here, that is, the ability to grow profits faster than revenue by improving margins rather than just chasing volume. For investors, this indicates Orica isn’t simply riding commodity prices but executing a genuine operational improvement strategy. Management’s confidence is evident in the announcement of a $500 million share buyback alongside increased dividends, demonstrating that the business now generates sustainable free cash flow rather than borrowing to fund returns.
The Valuation Reality: Good News Already Priced In
Here’s where the investment case becomes more nuanced. Despite delivering on expectations with the record profit, Orica’s share price barely moved post-announcement. This muted reaction tells us the market had already anticipated the strong result and baked much of the near-term upside into the current valuation. After a 40% single-year run, the stock now trades at approximately 17-18 times earnings, not expensive by historical standards, but no longer obviously cheap either.
Morningstar analysts noted that while fiscal 2025 was impressive, investors appear to be “ahead of themselves” at current levels. This suggests the market may be pricing in optimistic assumptions about sustained double-digit earnings growth that haven’t yet been proven. For context, Orica’s 52-week range spans from $14.88 to $23.95, meaning the stock is now trading near the top of that range with limited technical room to run without a fundamental catalyst.
The Investor’s Takeaway
Orica’s long-term investment case remains compelling, but timing matters significantly after a 40% single-year rally. The evidence suggests waiting for a better entry point makes more sense than buying at current levels.
For new investors: Wait for a pullback to the $18-20 range, a 15-20% correction that would provide better risk-reward. Following explosive runs, stocks typically consolidate before establishing their next leg higher. Let the stock come to you.
For current holders: Hold your positions. Jefferies highlights that Orica’s turnaround is still in early stages, with sustainable double-digit EPS growth achievable as mining activity expands and digital adoption increases. The $500 million buyback will provide price support.
Key risks to monitor: If mining activity slows or copper/gold prices correct sharply, earnings could face headwinds. This remains a cyclical business where valuation assumes favourable conditions continue.
In situations like this, the patient investor often wins. Orica has delivered an impressive result, but better entry points are likely ahead.
Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Why do ASX companies undertake share consolidations? Here are the 3 key reasons
Some microcap ASX stocks (particularly companies below 1c) will undertake share consolidations. There are several reasons why they undertake this,…
Rio Tinto’s ~US$35bn Simandou Mine in Guinea Is Go! Here’s What It Means for Investors
Nearly 3 decades since Rio Tinto first won exploration rights for Simandou, the mine was finally inaugurated. First shipments are…
ReNerve (ASX: RNV) Wins US Military and Veterans Healthcare Approval: 9.5 Million Patient Network Now Accessible
ReNerve (ASX: RNV) announced today its flagship NervAlign nerve cuff has been approved for use across the US Department of…
